fda drug shortages semaglutide injection shortage resolved 2025 date The Ozempic Is Over FDA Declares Shortage of Novo

Their approach includes scheduled lab work, heart health evaluations, and ongoing clinical support for patients using medications such as semaglutide, tirzepatide, Mounjaro, Wegovy, and Ozempic

4 Diabetes Care (PubMed) Hollander et al

The medication continues its work throughout the week, and resuming your normal schedule the following week maintains your therapeutic rhythm

According to FDA labeling, the common side effects include: Gastrointestinal effects (with frequencies varying by dose): Nausea (12-30% of patients, often most prominent during dose escalation) Diarrhea (7-22%) Vomiting (2-10%) Constipation (5-17%) Abdominal pain or discomfort (5-10%) Decreased appetite (5-10%) Dyspepsia/indigestion (2-9%) Gastroesophageal reflux disease (1-5%, more common in weight management indication) Eructation/belching (more common in weight management indication) These gastrointestinal symptoms typically occur early in treatment or following dose increases and often diminish over time as the body adjusts to the medication

6.1 Lack of national epidemiological data While isolated hospital-based and regional studies have reported local prevalence rates, there is currently no national registry or longitudinal cohort that captures the full scope of MAFLD across Vietnam